Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chenlian Quan"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Recent studies showed heterogeneity in stage IVB patients. However, few studies focused on the prognosis of supraclavicular metastatic ovarian cancer. This study aimed to explore the prognostic factors and the role of primary debu
Externí odkaz:
https://doaj.org/article/6403fdcdf5564dcbaccac4696964e17a
Publikováno v:
Gynecological Endocrinology, Vol 40, Iss 1 (2024)
AbstractAims The aim of this study was to investigate the impact of three single nucleotide polymorphisms (SNPs) within X-Ray Repair Cross Complementary Group 2 (XRCC2) gene and additional gene- abdominal obesity (AO) interaction with endometrial car
Externí odkaz:
https://doaj.org/article/e155cb4a67e147bfaa2a615cd71f863d
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Backgrounds Endometrial carcinoma (EC) is one of the most commonly diagnosed gynecologic malignancy in China. However, the genetic profile of Chinese EC patients has not been well established yet. Methods In current study, 158 Chinese EC pat
Externí odkaz:
https://doaj.org/article/7ac149d7b3e245a1b0523010a5284dca
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-23 (2023)
Abstract Background Cervical cancer is one of the most common gynecological cancers threatening women’s health worldwide. Double-stranded RNA-binding proteins (dsRBPs) regulate innate immunity and are therefore believed to be involved in virus-rela
Externí odkaz:
https://doaj.org/article/06282c122e79497a9c7d3dcb2dc60ab4
Autor:
Jing Si, Benlong Yang, Rong Guo, Naisi Huang, Chenlian Quan, Linxiaoxi Ma, Bingqiu Xiu, Yun Cao, Yue Tang, Linxiao Shen, Jiajian Chen, Jiong Wu
Publikováno v:
Cancer Biology & Medicine, Vol 16, Iss 2, Pp 312-318 (2019)
Objective Patients preoperatively diagnosed with ductal carcinoma in situ (DCIS) by core needle biopsy (CNB) exhibit a significant risk for upstaging on final pathology, which leads to major concerns of whether axillary staging is required at the pri
Externí odkaz:
https://doaj.org/article/43a47efdefd74edb8bdd02aea820a204
Autor:
Chenlian Quan1,2, Zhong Zheng1,2, Siyu Cao1,2, Yong Wu1,2, Wei Zhang1,2, Yan Huang1,2 huangyan1168@aliyun.com
Publikováno v:
Journal of Gynecologic Oncology. Jul2024, Vol. 35 Issue 4, p1-12. 12p.
Autor:
Naisi Huang, Benlong Yang, Bingqiu Xiu, Jiajian Chen, Yun Cao, Linxiaoxi Ma, Linxiao Shen, Jing Si, Chenlian Quan, Rong Guo, Jiong Wu, Yue Tang
Publikováno v:
Cancer Biology & Medicine, Vol 16, Iss 2, Pp 312-318 (2019)
Cancer Biology & Medicine
Cancer Biology & Medicine
Objective Patients preoperatively diagnosed with ductal carcinoma in situ (DCIS) by core needle biopsy (CNB) exhibit a significant risk for upstaging on final pathology, which leads to major concerns of whether axillary staging is required at the pri
Publikováno v:
Asian journal of surgery. 46(1)
To compare sugrical and survival outcomes between laparoscopic radical hysterectomy (LRH) and radical abdominal hysterectomy (RAH).All the patients with IB1-IIA2 cervical cancer who performed LRH or RAH in Fudan University Shanghai Cancer Center betw
Autor:
Jie Cheng, Hao Wen, Qin Hu, Shu Zhang, Jun Zhu, Chenlian Quan, Xiaohua Wu, Yan Huang, Zheng Feng
Publikováno v:
Molecular Therapy. Nucleic Acids
Ovarian cancer is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance to chemotherapeutic drugs such as paclitaxel (PTX) occurring in the very early stage is one of the important factors of the poor prognos
Publikováno v:
Cancer Medicine
The aim of this study was to investigate the trends of axillary lymph node evaluation in ductal carcinoma in situ (DCIS) patients treated with breast‐conserving therapy (BCT) and to identify the clinicopathological predictors of axillary evaluation